Nitric oxide signaling specificity - The heart of the problem

Journal of Cell Science

Volumn 116, Issue 1, 2003, Pages 9-15

  Bredt, David S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Heart; Nitrix oxide; PDZ domain; Protein targeting

Indexed keywords

CAVEOLIN; DYSTROPHIN; FREE RADICAL; LIPID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL CELL; BIOSYNTHESIS; CELL FUNCTION; DIFFUSION; DISEASE ASSOCIATION; HEART FUNCTION; HUMAN; HUMAN CELL; MEDIATOR; MOLECULAR BIOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CELL COMPARTMENTATION; DYSTROPHIN; EUKARYOTIC CELLS; HUMANS; MYOCARDIUM; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RECEPTORS, N-METHYL-D-ASPARTATE; REGIONAL BLOOD FLOW; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 0037235002     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.00183     Document Type: Review

References (85)

1. Adams, M. E., Mueller, H. A. and Froehner, S. C. (2001). In vivo requirement of the alpha-syntrophin PDZ domain for the sarcolemmal localization of nNOS and aquaporin-4. J. Cell Biol. 155, 113-122.
2. Anderson, R. G. (1998). The caveolae membrane system. Annu. Rev. Biochem. 67, 199-225.
3. Ayajiki, K., Kindermann, M., Hecker, M., Fleming, I. and Busse, R. (1996). Intracellular pH and tyrosine phosphorylation but not calcium determine shear stress-induced nitric oxide production in native endothelial cells. Circ. Res. 78, 750-758.
4. Barouch, L. A., Harrison, R. W., Skaf, M. W., Rosas, G. O., Cappola, T. P., Kobeissi, Z. A., Hobai, I. A., Lemmon, C. A., Burnett, A. L., O'Rourke, B. et al. (2002). Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms. Nature 416, 337-339.
5. Bloch, W., Fleischmann, B. K., Lorke, D. E., Andressen, C., Hops, B., Hescheler, J. and Addicks, K. (1999). Nitric oxide synthase expression and role during cardiomyogenesis. Cardiovasc. Res. 43, 675-684.
6. Bonnemann, C. G., McNally, E. M. and Kunkel, L. M. (1996). Beyond dystrophin: current progress in the muscular dystrophies. Curr. Opin. Pediatr. 8, 569-582.
7. Bredt, D. S. (1999). Knocking signalling out of the dystrophin complex. Nat. Cell Biol. 1, E89-E91
8. Bredt, D. S. and Snyder, S. H. (1989). Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proc. Natl. Acad. Sci. USA 86, 9030-9033.
9. Bredt, D. S. and Snyder, S. H. (1990). Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc. Natl. Acad. Sci. USA 87, 682-685.
10. Bredt, D. S., Hwang, P. M. and Snyder, S. H. (1990). Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature 347, 768-770.
11. Bredt, D. S., Hwang, P. M., Glatt, C. E., Lowenstein, C., Reed, R. R. and Snyder, S. H. (1991). Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase. Nature 351, 714-718.
12. Brenman, J. E. and Bredt, D. S. (1997). Synaptic signaling by nitric oxide. Curr. Opin. Neurobiol. 7, 374-378.
13. Brenman, J. E., Chao, D. S., Xia, H., Aldape, K. and Bredt, D. S. (1995). Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy. Cell 82, 743-752.
14. Brenman, J. E., Chao, D. S., Gee, S. H., McGee, A. W., Craven, S. E., Santillano, D. R., Huang, F., Xia, H., Peters, M. F., Froehner, S. C. et al. (1996). Interaction of nitric oxide synthase with the postsynaptic density protein PSD-95 and α-1 syntrophin mediated by PDZ motifs. Cell 84, 757-767.
15. Brouet, A., Sonveaux, P., Dessy, C., Moniotte, S., Balligand, J. L. and Feron, O. (2001). Hsp90 and caveolin are key targets for the proangiogenic nitric oxide- mediated effects of statins. Circ. Res. 89, 866-873.
16. Busconi, L. and Michel, T. (1993). Endothelial nitric oxide synthase. N-terminal myristoylation determines subcellular localization. J. Biol. Chem. 268, 8410-8413.
17. Campbell, K. P. (1995). Three muscular dystrophies: loss of cytoskeleton-extracellular matrix linkage. Cell 80, 675-679.
18. Casado, M., Isope, P. and Ascher, P. (2002). Involvement of presynaptic N-methyl-D-aspartate receptors in cerebellar long-term depression. Neuron 33, 123-130.
19. Chao, D. S., Gorospe, R. M., Brenman, J. E., Rafael, J. A., Peters, M. F., Froehner, S. C., Hoffman, E. P., Chamberlain, J. S. and Bredt, D. S. (1996). Selective loss of sarcolemmal nitric oxide synthase in Becker Muscular Dystrophy. J. Exp. Med. 184, 609-618.
20. Chao, D. S., Silvagno, F. and Bredt, D. S. (1998). Muscular dystrophy in mdx mice despite lack of neuronal nitric oxide synthase. J. Neurochem. 71, 784-789.
21. Cho, K. O., Hunt, C. A. and Kennedy, M. B. (1992). The rat brain postsynaptic density fraction contains a homolog of the Drosophila discs-large tumor suppressor protein. Neuron 9, 929-942.
22. Christopherson, K. S., Hillier, B. J., Lim, W. A. and Bredt, D. S. (1999). PSD-95 assembles a ternary complex with the N-methyl-D-aspartic acid receptor and a bivalent neuronal NO synthase PDZ domain. J. Biol. Chem. 274, 27467-27473.
23. Coyle, J. T. and Puttfarcken, P. (1993). Oxidative stress, glutamate, and neurodegenerative disorders. Science 262, 689-695.
24. Craven, S. E. and Bredt, D. S. (1998). PDZ proteins organize synaptic signaling pathways. Cell 93, 495-498.
25. Crosbie, R. H., Straub, V., Yun, H. Y., Lee, J. C., Rafael, J. A., Chamberlain, J. S., Dawson, V. L., Dawson, T. M. and Campbell, K. P. (1998). mdx muscle pathology is independent of nNOS perturbation. Hum. Mol. Gen. 7, 823-829.
26. Daniel, H., Levenes, C. and Crepel, F. (1998). Cellular mechanisms of cerebellar LTD. Trends Neurosci. 21, 401-407.
27. Dawson, V. L., Dawson, T. M., London, E. D., Bredt, D. S. and Snyder, S. H. (1991). Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc. Natl. Acad. Sci. USA 88, 6368-6371.
28. Dimmeler, S., Fleming, I., Fisslthaler, B., Hermann, C., Busse, R. and Zeiher, A. M. (1999). Activation of nitric oxide synthase in endothelial cells by Akt- dependent phosphorylation. Nature 399, 601-605.
29. Doyle, D. A., Lee, A., Lewis, J., Kim, E., Sheng, M. and MacKinnon, R. (1996). Crystal structures of a complexed and peptide-free membrane protein-binding domain: molecular basis of peptide recognition by PDZ. Cell 85, 1067-1076.
30. Drab, M., Verkade, P., Elger, M., Kasper, M., Lohn, M., Lauterbach, B., Menne, J., Lindschau, C., Mende, F., Luft, F. C. et al. (2001). Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science 293, 2449-2452.
31. Fang, M., Jaffrey, S. R., Sawa, A., Ye, K., Luo, X. and Snyder, S. H. (2000). Dexras1: a G protein specifically coupled to neuronal nitric oxide synthase via CAPON. Neuron 28, 183-193.
32. Feron, O., Belhassen, L., Kobzik, L., Smith, T. W., Kelly, R. A. and Michel, T. (1996). Endothelial nitric oxide synthase targeting to caveolae. Specific interactions with caveolin isoforms in cardiac myocytes and endothelial cells. J. Biol. Chem. 271, 22810-22814.
33. Fleming, I., Bauersachs, J., Schafer, A., Scholz, D., Aldershvile, J. and Busse, R. (1999). Isometric contraction induces the Ca2+-independent activation of the endothelial nitric oxide synthase. Proc. Natl. Acad. Sci. USA 96, 1123-1128.
34. Fulton, D., Gratton, J. P., McCabe, T. J., Fontana, J., Fujio, Y., Walsh, K., Franke, T. F., Papapetropoulos, A. and Sessa, W. C. (1999). Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 399, 597-601.
35. Furchgott, R. F. and Zawadzki, J. V. (1980). The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288, 373-376.
36. Garcia-Cardena, G., Fan, R., Stern, D. F., Liu, J. and Sessa, W. C. (1996a). Endothelial nitric oxide synthase is regulated by tyrosine phosphorylation and interacts with caveolin-1. J. Biol. Chem. 271, 27237-27240.
37. Garcia-Cardena, G., Oh, P., Liu, J., Schnitzer, J. E. and Sessa, W. C. (1996b). Targeting of nitric oxide synthase to endothelial cell caveolae via palmitoylation: implications for nitric oxide signaling. Proc. Natl. Acad. Sci. USA 93, 6448-6453.
38. Garcia-Cardena, G., Fan, R., Shah, V., Sorrentino, R., Cirino, G., Papapetropoulos, A. and Sessa, W. C. (1998). Dynamic activation of endothelial nitric oxide synthase by Hsp90. Nature 392, 821-824.
39. Garner, C. C., Nash, J. and Huganir, R. L. (2000). PDZ domains in synapse assembly and signalling. Trends Cell Biol. 10, 274-280.
40. Garthwaite, J. and Boulton, C. L. (1995). Nitric oxide signaling in the central nervous system. Annu. Rev. Physiol. 57, 683-706.
41. Grady, R. M., Grange, R. W., Lan, K. S., Maimone, M. M., Nichol, M. C., Stull, J. T. and Sanes, J. R. (1999). Role for alpha-dystrobrevin in the pathogenesis of dystrophin-dependent muscular dystrophies. Nat. Cell Biol. 1, 215-220.
42. Gratton, J. P., Fontana, J., O'Connor, D. S., Garcia-Cardena, G., McCabe, T. J. and Sessa, W. C. (2000). Reconstitution of an endothelial nitric-oxide synthase (eNOS), hsp90, and caveolin-1 complex in vitro. Evidence that hsp90 facilitates calmodulin stimulated displacement of eNOS from caveolin-1. J. Biol. Chem. 275, 22268-22272.
43. Harris, B. Z., Venkatasubrahmanyam, S. and Lim, W. A. (2002). Coordinated folding and association of the Lin-2, -7 (127) domain. An obligate heterodimerization module involved in assembly of signaling and cell polarity complexes. J. Biol. Chem. 277, 34902-34908.
44. Hibbs, J. B., Jr, Taintor, R. R. and Vavrin, Z. (1987). Macrophage cytotoxicity: role for L-arginine deiminase and imino nitrogen oxidation to nitrite. Science 235, 473-476.
45. Hillier, B. J., Christopherson, K. S., Prehoda, K. E., Bredt, D. S. and Lim, W. A. (1999). Unexpected modes of PDZ domain scaffolding revealed by structure of nNOS-syntrophin complex. Science 284, 812-815.
46. Hobbs, A. J. and Ignarro, L. J. (1996). Nitric oxide-cyclic GMP signal transduction system. Methods Enzymol. 269, 134-148.
47. Jaffrey, S. R., Snowman, A. M., Eliasson, M. J., Cohen, N. A. and Snyder, S. H. (1998). CAPON: a protein associated with neuronal nitric oxide synthase that regulates its interactions with PSD95. Neuron 20, 115-124.
48. Jaffrey, S. R., Benfenati, F., Snowman, A. M., Czernik, A. J. and Snyder, S. H. (2002). Neuronal nitric-oxide synthase localisation mediated by a ternary complex with synapsin and CAPON. Proc. Natl. Acad. Sci. USA 99, 3199-3204.
49. Ju, H., Zou, R., Venema, V. J. and Venema, R. C. (1997). Direct interaction of endothelial nitric-oxide synthase and caveolin-1 inhibits synthase activity. J. Biol. Chem. 272, 18522-18525.
50. Kameya, S., Miyagoe, Y., Nonaka, I., Ikemoto, T., Endo, M., Hanaoka, K., Nabeshima, Y. and Takeda, S. (1999). alpha1-syntrophin gene disruption results in the absence of neuronal-type nitric-oxide synthase at the sarcolemma but does not induce muscle degeneration. J. Biol. Chem. 274, 2193-2200.
51. Kiedrowski, L., Costa, E. and Wroblewski, J. T. (1992). Glutamate receptor agonists stimulate nitric oxide synthase in primary cultures of cerebellar granule cells. J. Neurochem. 58, 335-341.
52. Kistner, U., Wenzel, B. M., Veh, R. W., Cases-Langhoff, C., Garner, A. M., Appeltauer, U., Voss, B., Gundelfinger, E. D. and Garner, C. C. (1993). SAP90, a rat presynaptic protein related to the product of the Drosophila tumor suppressor gene dlg-A. J. Biol. Chem. 268, 4580-4583.
53. Knowles, R. G., Palacios, M., Palmer, R. M. and Moncada, S. (1989). Formation of nitric oxide from L-arginine in the central nervous system: a transduction mechanism for stimulation of the soluble guanylate cyclase. Proc. Natl. Acad. Sci. USA 86, 5159-5162.
54. Kobzik, L., Reid, M. B., Bredt, D. S. and Stamler, J. S. (1994). Nitric oxide in skeletal muscle. Nature 372, 546-548.
55. Kornau, H.-C., Seeburg, P. H. and Kennedy, M. B. (1997). Interaction of ion channels and receptors with PDZ domains. Curr. Opin. Neurobiol. 7, 368-373.
56. Lev-Ram, V., Nebyelul, Z., Ellisman, M. H., Huang, P. L. and Tsien, R. Y. (1997). Absence of cerebellar long-term depression in mice lacking neuronal nitric oxide synthase. Learn Mem. 4, 169-177.
57. Lipton, S. A. and Rosenberg, P. A. (1994). Excitatory amino acids as a final common pathway for neurologic disorders. New Engl. J. Med. 330, 613-622.
58. Lisanti, M. P., Tang, Z., Scherer, P. E., Kubler, E., Koleske, A. J. and Sargiacomo, M. (1995). Caveolae, transmembrane signalling and cellular transformation. Mol. Membr. Biol. 12, 121-124.
59. McDonald, L. J. and Murad, F. (1995). Nitric oxide and cGMP signaling. Adv. Pharmacol. 34, 263-275.
60. Meffert, M. K., Calakos, N. C., Scheller, R. H. and Schulman, H. (1996). Nitric oxide modulates synaptic vesicle docking fusion reactions. Neuron 16, 1229-1236.
61. Moriyoshi, K., Masu, M., Ishii, T., Shigemoto, R., Mizuno, N. and Nakanishi, S. (1991). Molecular cloning and characterization of the rat NMDA receptor. Nature 354, 31-37.
62. Olney, J. W., Labruyere, J. and Price, M. T. (1989). Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science 244, 1360-1362.
63. Palmer, R. M. and Moncada, S. (1989). A novel citrulline-forming enzyme implicated in the formation of nitric oxide by vascular endothelial cells. Biochem. Biophys. Res. Commun. 158, 348-352.
64. Papapetropoulos, A., Garcia-Cardena, G., Madri, J. A. and Sessa, W. C. (1997). Nitric oxide, production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. J. Clin. Invest. 100, 3131-3139.
65. Pollock, J. S., Forstermann, U., Mitchell, J. A., Warner, T. D., Schmidt, H. H., Nakane, M. and Murad, F. (1991). Purification and characterization of particulate endothelium-derived relaxing factor synthase from cultured and native bovine aortic endothelial cells. Proc. Natl. Acad. Sci. USA 88, 10480-10484.
66. Robinson, L. J., Busconi, L. and Michel, T. (1995). Agonist-modulated palmitoylation of endothelial nitric oxide synthase. J. Biol. Chem. 270, 995-998.
67. Sattler, R., Xiong, Z., Lu, W.-Y., Hafner, M., MacDonald, J. F. and Tymianski, M. (1999). Specific coupling of NMDA receptor activation to nitric oxide neurotoxicity by PSD-95 protein. Science 284, 1845-1848.
68. Schultz, G., Rosenthal, W., Hescheler, J. and Trautwein, W. (1990). Role of G proteins in calcium channel modulation. Annu. Rev. Physiol. 52, 275-292. '
69. Schultz, J., Copley, R. R., Doerks, T., Ponting, C. P. and Bork, P. (2000). SMART: a web-based tool for the study of genetically mobile domains. Nucleic Acids Res. 28, 231-234.
70. Schwencke, C., Yamamoto, M., Okumura, S., Toya, Y., Kim, S. J. and Ishikawa, Y. (1999). Compartmentation of cyclic adenosine 3′,5′-monophosphate signaling in caveolae. Mol. Endocrinol. 13, 1061-1070.
71. Sessa, W. C., Barber, C. M. and Lynch, K. R. (1993). Mutation of N-myristoylation site converts endothelial cell nitric oxide synthase from a membrane to a cytosolic protein. Circ. Res. 72, 921-924.
72. Shaul, P. W., Smart, E. J., Robinson, L. J., German, Z., Yuhanna, I. S., Ying, Y., Anderson, R. G. and Michel, T. (1996). Acylation targets emdothelial nitric-oxide synthase to plasmalemmal caveolae. J. Biol. Chem. 271, 6518-6522.
73. Sheng, M. (2001). The postsynaptic NMDA-receptor-PSD-95 signaling complex in excitatory synapses of the brain. J. Cell Sci. 114, 1251.
74. Silvagno, F., Xia, H. and Bredt, D. S. (1996). Neuronal nitric oxide synthase-m, an alternatively spliced isoform expressed in differentiated skeletal muscle. J. Biol. Chem. 271, 11204-11208.
75. Snyder, S. H. and Bredt, D. S. (1992). Biological roles of nitric oxide. Sci. Am. 266, 68-77.
76. Stamler, J. S., Lamas, S. and Fang, F. C. (2001). Nitrosylation. the prototypic redox-based signaling mechanism. Cell 106, 675-683.
77. Stricker, N. L., Christopherson, K. S., Yi, B. A., Schutz, P. J., Raab, R. W., Dawes, G., Bassett, D. E., Jr, Bredt, D. S. and Li, M. (1997). PDZ Domain of neuronal nitric oxide synthase recognizes novel C-terminal peptide sequences as determined by in vitro selection. Nat. Biotech. 15, 336-342.
78. Thomas, G. D., Sander, M., Lau, K. S., Huang, P. L., Stull, J. T. and Victor, R. G. (1998). Impaired metabolic modulation of alpha-adrenergic vasoconstriction in dystrophin-deficient skeletal muscle. Proc. Natl. Acad. Sci. USA 95, 15090-15095.
79. Thomas, G. D. and Victor, R. G. (1998). Nitric oxide mediates contraction-induced attenuation of sympathetic vasoconstriction in rat skeletal muscle. J. Physiol. 506, 817-826.
80. Tochio, H., Mok, Y. K., Zhang, Q., Kan, H. M., Bredt, D. S. and Zhang, M. (2000). Formation of nNOS/PSD-95 PDZ dimer requires a preformed beta-finger structure from the nNOS PDZ domain. J. Mol. Biol. 303, 359-370.
81. Wehling, M., Spencer, M. J. and Tidball, J. G. (2001). A nitric oxide synthase transgene ameliorates muscular dystrophy in mdx mice. J. Cell Biol. 155, 123-131.
82. Xu, K. Y., Huso, D. L., Dawson, T. M., Bredt, D. S. and Becker, L. C. (1999). Nitric oxide synthase in cardiac sarcoplasmic reticulum. Proc. Natl. Acad. Sci. USA 96, 657-662.
83. Xu, L., Eu, J. P., Meissner, G. and Stamler, J. S. (1998). Activation of the cardiac calcium release channel (ryanodine receptor) by poly-S-nitrosylation. Science 279, 234-237.
84. Yeh, D. C., Duncan, J. A., Yamashita, S. and Michel, T. (1999). Depalmitoylation of endothelial nitric-oxide synthase by acyl-protein thioesterase 1 is potentiated by Ca(2+)-calmodulin. J. Biol. Chem. 274, 33148-33154.
85. Zeng, G. and Quon, M. J. (1996). Insulin-stimulated production of nitric oxide is inhibited by wortmannin. Direct measurement in vascular endothelial cells. J. Clin. Invest. 98, 894-898.